Legend Capital has invested in a $32.6m round raised by Axonics Modulation Technologies, which is developing technology to treat chronic pain.

The corporates will collaborate with Ohio State University and several venture capital firms on a $140m programme intended to develop healthcare startups.

GE and Mayo Clinic were among the investors in the round, which Chrono intends to use to the capital to complete its digital aid for stopping smoking.

Aduro Biotech has now raised $84m after securing Johnson & Johnson as a new investor alongside Morningside and several undisclosed backers.

The university signs a licensing deal with the Canadian biotech.

Celgene secured the money two months after raising $100m from the Kuwait Investment Authority and additional funding from Blackberry.

The pharmaceutical company has set the range for its initial public offering, which will see Johnson & Johnson become a notable shareholder.

The Amgen-backed biopharmaceutical company is set to generate up to $54m from its initial public offering, after pulling in $59.5m in equity funding since its formation.

Seres has now secured $20.5m in funding after Mayo Clinic joined existing investors Enso and Flagship.